PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds biologic therapies for rheumatoid arthritis not associated with increased cancer risk

Largest systematic review provides the most current information on class of drugs available to patients

2012-09-05
(Press-News.org) HOUSTON – Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.

The study, published in The Journal of the American Medical Association (JAMA), is the largest systematic review evaluating the risk of developing any malignancy among rheumatoid arthritis patients using approved biologic response modifiers (BRMs), several of which include tumor necrosis factor (TNF) inhibitors. Since 2005, conflicting data has associated TNF inhibitors with an increased risk of developing certain types of malignancies. Because of increased cases of spontaneous lymphoma in children and adolescents, the current US Food and Drug Administration warning label notes the risk of malignancy for all TNF inhibitors.

"These results are reassuring for patients considering biologic therapies for their disease," says senior author Maria E. Suarez-Almazor, M.D., professor in the Department of General Internal Medicine at MD Anderson. "Patients are understandably concerned when treatments are linked to cancer risk. With this knowledge, clinicians can effectively demonstrate that the benefits of BRMs far outweigh the risk."

Rheumatoid arthritis affects approximately one percent of the population and can lead to significant morbidity, joint deformity and impaired quality of life. Traditional treatments for rheumatoid arthritis include disease-modifying anti-rheumatic drugs (DMARDs), like methotrexate, and anti-inflammatory medications.

BRMs are prescribed as a second line of treatment if the initial DMARDs fail. BRMs target molecules on cells of the immune system and joints, and the products that are secreted in the joints, all of which can cause inflammation and joint destruction. Between 25 and 56 percent of patients use BRMs to treat the disease, but concerns over cancer risk abound because the therapies interfere with the immune system.

The researchers – part of MD Anderson's team of internal medicine specialists dedicated to treating cancer patients for medical issues other than cancer – used the Cochrane Collaboration to analyze the results of 29,423 adult patients from 63 randomized controlled trials. As a group, the trials selected compared the safety of all nine BRMs currently approved by the FDA against a placebo or traditional DMARD and included only patients with rheumatoid arthritis who had a minimum of six months of follow-up. The Cochrane Collection is an independent, non-profit organization that houses the largest collection of records of randomized controlled trials in the world.

They observed no statistically significant increased risk of any type of cancer in patients treated with BRMs compared with the other medications. In the trials analyzed, 211 patients developed a malignancy during the trial. No significant differences existed between patients in the control group who developed cancer versus those treated with BRM therapies.

"Although additional reviews of observational studies are needed to establish any long-term risk, this is a step forward in understanding overall the risk of developing cancer when taking this newer class of medication," says Suarez-Almazor. "With these results patients and clinicians can make informed decisions about treating rheumatoid arthritis."

###

In addition to Suarez-Almazor, other researchers contributing to the study include: Maria A. Lopez-Olivo, M.D., and Jean H. Tayar, M.D., of the Department of General Internal Medicine at MD Anderson; Stephanie Fulton, MSIS, executive director of the Research Medical Library at MD Anderson; Juan A. Martinez-Lopez, M.D., of the Spanish Society of Rheumatology; Eduardo N. Pollono, M.D., of Texas Tech University Health Science Center; Jose Polo Cueto, M.D., of Manati Medical Center (Manati, Puerto Rico); and M. Rosa Gonzales-Crespo, M.D., of the Hospital 12 de Octubre (Madrid, Spain).

END



ELSE PRESS RELEASES FROM THIS DATE:

In elk hunting, success depends on the animal's personality

2012-09-05
(Edmonton) University of Alberta led research shows an elk's personality type is a big factor in whether or not it survives the hunting season. Data collected from GPS collars on more than 100 male and female elk in southwestern Alberta showed U of A researchers the study population could be divided into two categories: bold runners and shy hiders: Bold-runner elk, both males and females, moved quickly through the study area and preferred to graze in open fields for the most abundant and nutritious grass. GPS data showed shy hiders stayed and grazed on the sparse vegetation ...

Health-care costs hit the elderly hard, diminish financial wellbeing

2012-09-05
The protection of the savings of the elderly—one of the primary goals of Medicare—is under threat from a combination of spiraling healthcare costs and increased longevity. As the government attempts to reduce Medicare costs, one suggestion is that the elderly could pay a larger proportion of the costs of their healthcare. But exactly how much would this be and what impact would it have on their finances? A new study by Amy Kelley at the Mount Sinai School of Medicine and her colleagues, funded by the National Institute on Aging, aims to identify the portion of wealth ...

NASA sees the short life of Tropical Depression John

NASA sees the short life of Tropical Depression John
2012-09-05
Tropical Storm John had about one day of fame in the Eastern Pacific. Born Tropical Depression 10, it intensified into Tropical Storm John on Sept. 2 at 5 a.m. EDT and maintained maximum sustained winds of 40 mph (65 kmh) until it weakened back into a depression on Monday, Sept. 3 at 11 p.m. EDT. NASA's Aqua satellite flew over John on Sept. 3 at 2041 UTC (4:41 p.m. EDT) during its brief time as a tropical storm and noticed convection (rising air that forms thunderstorms that make up the storm) and coldest cloud top temperatures seemed to be limited to the northeastern ...

NASA satellites showed little change in Tropical Storm Leslie

NASA satellites showed little change in Tropical Storm Leslie
2012-09-05
Over the weekend of Aug. 31 to Sept. 2, Tropical Storm Leslie's maximum sustained winds were pretty constant and satellite imagery from NASA's Aqua and Terra satellites confirm the steadiness of the storm. That story is expected to change later this week however, as Leslie nears Bermuda and is expected to reach hurricane strength. Meanwhile, Leslie is still about the same strength today, Sept. 4 because of wind shear. Two visible images from the Moderate Resolution Imaging Spectroradiometer or MODIS instrument that flies onboard both of NASA's Aqua and Terra satellites ...

Newborn Tropical Storm Michael struggling like Leslie and Isaac

Newborn Tropical Storm Michael struggling like Leslie and Isaac
2012-09-05
Tiny Tropical Storm Michael formed today, Sept. 4, from the thirteenth tropical depression in the Atlantic Ocean, but it seems that wind shear will make Michael struggle to intensify over the next couple of days like his "sister" Tropical Storm Leslie. Isaac's remnants blanket the U.S. east coast. Leslie has been a tropical storm since late Aug. and has not yet reached hurricane strength because of wind shear, although that is expected to change. Isaac's remnants are also struggling, but struggling to get off the land and back into the Atlantic Ocean. Isaac's remnants ...

Scripps Florida scientists design molecule that reverses some fragile X syndrome defects

Scripps Florida scientists design molecule that reverses some fragile X syndrome defects
2012-09-05
JUPITER, FL - Scientists on the Florida campus of The Scripps Research Institute have designed a compound that shows promise as a potential therapy for one of the diseases closely linked to fragile X syndrome, a genetic condition that causes mental retardation, infertility, and memory impairment, and is the only known single-gene cause of autism. The study, published online ahead of print in the journal ACS Chemical Biology September 4, 2012, focuses on tremor ataxia syndrome, which usually affects men over the age of 50 and results in Parkinson's like-symptoms—trembling, ...

Violent video games not so bad when players cooperate

2012-09-05
COLUMBUS, Ohio – New research suggests that violent video games may not make players more aggressive – if they play cooperatively with other people. In two studies, researchers found that college students who teamed up to play violent video games later showed more cooperative behavior, and sometimes less signs of aggression, than students who played the games competitively. The results suggest that it is too simplistic to say violent video games are always bad for players, said David Ewoldsen, co-author of the studies and professor of communication at Ohio State University. "Clearly, ...

Longer CPR attempts might benefit some patients, U-M research finds

2012-09-05
There isn't a hard and fast rule for how long doctors should perform CPR, but new research from the University of Michigan Health System shows longer attempts might be beneficial for some patients. Most cardiac arrest patients are often successfully resuscitated after a short period of time – about 12 minutes on average. Practitioners are often reluctant to perform longer attempts – those that can last 30 minutes or longer – because if patients do not survive early on during cardiac arrest, their overall prognosis is poor. The research from U-M, however, shows that ...

Rare genetic disease offers insight into common cancers

2012-09-05
Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing a variety of cancers, especially leukemias and head and neck cancer. Cruelly, the condition also nixes the use of an entire class of cancer drugs, namely drugs like mitomycin C that act by encouraging DNA to crosslink together like sticky strands of bread dough – generally, healthy cells can repair a few crosslinks whereas cancer cells cannot and so are killed. However, ...

Brian Dickinson Keynote Speaker for Project Management Institute Believes Businesses Must Stop Using Industrial-Age Organizational Structures that Create Complexity and Inefficiency in their Systems

2012-09-05
Brian Dickinson President of Logical Conclusions Inc. http://www.EventDrivenConcepts.com has been invited to give a keynote speech at the Project Management Institute's annual Professional Development Day on the 28th September 2012 in Honolulu Hawaii. As an author of many books and an expert in business improvement and reengineering concepts Dickinson will explain why he believes the vast majority of businesses, both public and private, are stuck in an old industrial-age paradigm leading to inefficient manual and computer systems that are not responsive to their customers ...

LAST 30 PRESS RELEASES:

One in four chance per year that rocket junk will enter busy airspace

Later-onset menopause linked to healthier blood vessels, lower heart disease risk

New study reveals how RNA travels between cells to control genes across generations

Women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

GLP-1 drug shows little benefit for people with Parkinson’s disease

Generally, things really do seem better in morning, large study suggests

Juicing may harm your health in just three days, new study finds

Forest landowner motivation to control invasive species depends on land use, study shows

Coal emissions cost India millions in crop damages

$10.8 million award funds USC-led clinical trial to improve hip fracture outcomes

University Hospitals Cleveland Medical Center among most reputable academic medical centers

Emilia Morosan on team awarded Kavli Foundation grant for quantum geometry-enabled superconductivity

Unlock sales growth: Implement “buy now, pay later” to increase customer spending

Research team could redefine biomedical research

Bridging a gap in carbon removal strategies

Outside-in signaling shows a route into cancer cells

NFL wives bring signature safe swim event to New Orleans

Pickleball program boosts health and wellness for cancer survivors, Moffitt study finds

International Alzheimer’s prevention trial in young adults begins

Why your headphone battery doesn't last

Study probes how to predict complications from preeclampsia

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

NYU’s Yann LeCun a winner of the 2025 Queen Elizabeth Prize for Engineering

New study assesses impact of agricultural research investments on biodiversity, land use

High-precision NEID spectrograph helps confirm first Gaia astrometric planet discovery

ABT-263 treatment rejuvenates aged skin and enhances wound healing

The challenge of pursuit – how saccades enable mammals to simultaneously chase prey and navigate through complex environments

Music can touch the heart, even inside the womb

Contribution of cannabis use disorder to new cases of schizophrenia has almost tripled over the past 17 years

[Press-News.org] Study finds biologic therapies for rheumatoid arthritis not associated with increased cancer risk
Largest systematic review provides the most current information on class of drugs available to patients